Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 22 of the 23 references it cites were found in a registry or an index; 10 of the 29 sources its claims cite were checked for support.

Prehospital Administration of Aspirin and Nitroglycerin for Patients With Suspected Acute Coronary Syndrome ― A Systematic Review ―

Open access
Nakayama, Naoki, Yamamoto, Takeshi, Kikuchi, Migaku, Hanada, Hiroyuki, Mano, Toshiaki, Nakashima, Takahiro, Hashiba, Katsutaka, Tanaka, Akihito, Matsuo, Kunihiro, Nomura, Osamu, Kojima, Sunao, Yamaguchi, Junichi, Matoba, Tetsuya, Tahara, Yoshio, Nonogi, Hiroshi, for the Japan Resuscitation Council (JRC) Acute Coronary Syndrome (ACS) Task Force and the Guideline Editorial Committee on behalf of the Japanese Circulation Society (JCS) Emergency and Critical Care Committee · 2022 · Circulation Reports

Abstract

Our systematic reviews suggest that prehospital administration of aspirin and nitroglycerin by non-physician healthcare professionals is beneficial for patients with suspected ACS, although the certainty of evidence is very low. Further investigation is needed to determine the benefit of the prehospital administration of these agents.

Overview

CoChat Summary

## TL;DR

This systematic review found that prehospital aspirin and nitroglycerin given by non-physician healthcare professionals were associated with lower mortality in observational studies of patients ultimately diagnosed with acute myocardial infarction. However, the certainty of evidence was rated very low for both drugs.

## Key findings

  • For prehospital aspirin, 3 observational studies (4,350 patients) found lower 30-day mortality with prehospital vs in-hospital aspirin: 93/2,193 (4.2%) vs 160/2,157 (7.4%); OR 0.59 (95% CI 0.35–0.99).
  • In 1 observational study (1,726 patients), prehospital aspirin was also associated with lower 1-year mortality: 102/995 (10.3%) vs 143/731 (19.6%); OR 0.47 (95% CI 0.36–0.62).
  • For prehospital nitroglycerin, 1 observational study (1,726 patients) found lower 30-day mortality: 52/1,142 (4.6%) vs 71/584 (12.2%); OR 0.34 (95% CI 0.24–0.50).
  • The same nitroglycerin study found lower 1-year mortality: 114/1,142 (10.0%) vs 131/584 (22.4%); OR 0.38 (95% CI 0.29–0.50). No significant differences were found for aspirin in reinfarction, stroke, or major hemorrhage.

## Methods

  • Systematic review and meta-analysis conducted for 2 clinical questions: prehospital aspirin and prehospital nitroglycerin for adult patients with suspected ACS, administered by non-physician healthcare professionals.
  • PubMed was searched for English-language RCTs and non-randomized studies published before August 14, 2020 for aspirin and before July 15, 2020 for nitroglycerin.
  • Results were pooled using a random-effects model; risk of bias was assessed with the Cochrane tool, and certainty of evidence was rated with GRADE.

## Limitations

  • The paper states the certainty of evidence was very low for both drugs because of risk of bias, imprecision, and indirectness.
  • The review included no RCTs; it relied on 3 observational studies for aspirin and 1 observational study for nitroglycerin.
  • The authors note they searched only PubMed and limited inclusion to English-language studies, which may have missed relevant evidence.
  • Evident from the text: all included studies were in patients ultimately diagnosed with AMI, not the broader population of suspected ACS.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1253/circrep.cr-22-0060

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1. Flow diagram summarizing the evidence search and study selection for aspirin.
Figure 1. Flow diagram summarizing the evidence search and study selection for aspirin.CC BY-NC-ND · PubMed Central
Figure 2. Forest plot for each outcome following prehospital aspirin administration: (A) 30-day mortality, (B) 1-year mortality, (C) reinfarction, (D) stroke, and (E) major hemorrhage.
Figure 2. Forest plot for each outcome following prehospital aspirin administration: (A) 30-day mortality, (B) 1-year mortality, (C) reinfarction, (D) stroke, and (E) major hemorrhage.CC BY-NC-ND · PubMed Central
Figure 3. Flow diagram summarizing the evidence search and study selection for nitroglycerin.
Figure 3. Flow diagram summarizing the evidence search and study selection for nitroglycerin.CC BY-NC-ND · PubMed Central
Figure 4. Forest plot for each outcome following prehospital nitroglycerin (NTG) administration: (A) 30-day and (B) 1-year mortality.
Figure 4. Forest plot for each outcome following prehospital nitroglycerin (NTG) administration: (A) 30-day and (B) 1-year mortality.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

7 Valid · 1 Not valid · 11 Not checked · 14 Own results and interpretations

13 more claims

Create a free account to see all 33 claims and to verify the 4 references still open.

See all claims — free account
  • It may state two separate claims as one. 6
  • Probably not a substantial claim. 11

Create a free account to see these claims.

Citations

Cites

Show all 23 references

Research works printed but not linked: 2

  1. 8. Japan Resuscitation Council Guidelines 2010. Chapter 5, Acute coronary syndrome, Herusu Shuppan, 2011.
  2. 9. Japan Resuscitation Council Guidelines 2015. Chapter 5, Acute coronary syndrome, Igaku-Shoin, 2016.

Cited by

See all 18

Metadata

Authors
Nakayama, N., Yamamoto, T., Kikuchi, M., Hanada, H., Mano, T., Nakashima, T., Hashiba, K., Tanaka, A., Matsuo, K., Nomura, O., Kojima, S., Yamaguchi, J., Matoba, T., Tahara, Y., Nonogi, H., & for the Japan Resuscitation Council (JRC) Acute Coronary Syndrome (ACS) Task Force and the Guideline Editorial Committee on behalf of the Japanese Circulation Society (JCS) Emergency and Critical Care Committee
Affiliations
  • Kanagawa Cardiovascular and Respiratory Center (JP)
  • Nippon Medical School Hospital (JP)
  • Dokkyo University (JP)
  • Hirosaki University (JP)
  • Kansai Rosai Hospital (JP)
  • University of Michigan (US)
  • Saiseikai Yokohama-shi Nanbu Hospital (JP)
  • Nagoya University (JP)
  • Fukuoka University (JP)
  • Department of Internal Medicine, Sakurajyuji Yatsushiro Rehabilitation Hospital
  • Tokyo Women's Medical University (JP)
  • Kyushu University (JP)
  • National Cerebral and Cardiovascular Center (JP)
  • Osaka Aoyama University (JP)
Corresponding author
Kikuchi, Migaku
Venue
Circulation Reports
Published
2022-10-07
Volume
4
Issue
10
Pages
449-457
ISSN
2434-0790 (ISSN-L)
OpenAlex
W4288057980
Cited by
18
References
23
Citations by year
2026: 6 · 2025: 1 · 2024: 5 · 2023: 4 · 2022: 2
FWCI
0.61
Type
journal article
Language
en
Open access
Licence
cc-by-nc-nd
Locations
  • Circulation Reports (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
Funders
  • Japanese Circulation Society
  • Sahlgrenska Universitetssjukhuset
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Acute Myocardial Infarction Research
  • Health Sciences › Medicine › Emergency Medicine › Cardiac Arrest and Resuscitation
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Antiplatelet Therapy and Cardiovascular Diseases
Keywords
aspirin, nitroglycerin, acute coronary syndrome, prehospital care, emergency medical services, chest pain

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (qwen3.8-omni-flash and gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Prehospital Administration of Aspirin and Nitroglycerin for Patients With Suspected Acute Coronary Syndrome ― A Systematic Review ―. https://app.cochat.ai/papers/10.1253/circrep.cr-22-0060
The paper
Nakayama, N., Yamamoto, T., Kikuchi, M., Hanada, H., Mano, T., Nakashima, T., Hashiba, K., Tanaka, A., Matsuo, K., Nomura, O., Kojima, S., Yamaguchi, J., Matoba, T., Tahara, Y., Nonogi, H., & for the Japan Resuscitation Council (JRC) Acute Coronary Syndrome (ACS) Task Force and the Guideline Editorial Committee on behalf of the Japanese Circulation Society (JCS) Emergency and Critical Care Committee. (2022). Prehospital Administration of Aspirin and Nitroglycerin for Patients With Suspected Acute Coronary Syndrome ― A Systematic Review ―. Circulation Reports. https://doi.org/10.1253/circrep.cr-22-0060

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.